Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

3rd Quarter Results

9 Dec 2020 07:00

RNS Number : 9949H
Marble Point Loan Financing Limited
09 December 2020
 

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IT IS NOT AN OFFER TO PURCHASE, OR A SOLICITATION OF AN OFFER TO SELL, ANY NOTES OR OTHER SECURITIES.

 

 

 

9 December 2020

 

 

 

Marble Point Loan Financing Limited

(the "Company")

 

Publication of Q3 2020 Unaudited Consolidated Financial Statements

 

 

The Board of Directors of the Company is pleased to release the Company's Q3 2020 Unaudited Consolidated Financial Statements for the period ending 30 September 2020.

 

In addition, the Company has made available certain additional information for noteholders of the 7.50% Senior Notes Due 16 November 2025. This information together with the Q3 2020 Unaudited Consolidated Financial Statements is available on the Company's website.

 

Click on, or paste the following link into your web browser, to view the Q3 2020 Unaudited Consolidated Financial Statements.

 

http://www.rns-pdf.londonstockexchange.com/rns/9949H_1-2020-12-8.pdf

The Q3 Unaudited Consolidated Financial Statements will also be available on the Company's website at:

 

 www.mplflimited.com 

 

 

Enquiries:

 

Marble Point Loan Financing Limited

Investor Relations

Tel.: +44 (0) 20 7259 1500

Email: ir@mplflimited.com

 

Corporate Broker

Stifel Nicolaus Europe Limited

T: +44 (0) 20 7710 7600

 

Financial Public Relations

Charlie Barker / Catherine Chapman

MHP Communications

P: +44 (0) 20 3128 8100

MarblePoint@mhpc.com

 

Past performance is not indicative or a guarantee of future performance.

ABOUT MARBLE POINT LOAN FINANCING LIMITED

About Marble Point Loan Financing

Marble Point Loan Financing Ltd. (LSE Ticker: MPLF LN (USD); MPLS LN (GBX)) is a Guernsey-domiciled closed-ended investment company. MPLF's investment objective is to generate stable current income and grow net asset value by earning a return on equity in excess of the amount distributed as dividends.

MPLF is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans owned via collateralised loan obligations ("CLOs") and related vehicles managed by Marble Point Credit Management LLC ("Marble Point") or its affiliates. Marble Point is an investment adviser registered with the U.S. Securities and Exchange Commission.

 

About Marble Point Credit Management LLC

Marble Point Credit Management LLC ("Marble Point") is a specialist asset manager focused exclusively on leveraged loans. Marble Point was founded by Thomas Shandell in partnership with Eagle Point Credit Management, a leading investor in CLO securities.

IMPORTANT INFORMATION

Marble Point Loan Financing Limited (the "Company") is a closed-ended investment company incorporated in Guernsey with its ordinary shares ("Shares") admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange (ticker: MPLF.LN). The Company is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans via CLOs, loan accumulation facilities and other vehicles managed by Marble Point Credit Management LLC ("Marble Point") or its affiliates. Marble Point is an investment adviser registered with the U.S. Securities and Exchange Commission.

This document is for information purposes only and has been issued by, and is the sole responsibility of, the Company. This document and the information and views included herein do not constitute investment advice, or a recommendation or an offer to enter into any transaction with the Company or any of its affiliates. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of any investment and should consult its own legal counsel and financial, actuarial, accounting, regulatory and tax advisers to evaluate any such investment. This document is provided for informational purposes only, does not constitute an offer to sell shares issued by the Company (the "Shares") or a solicitation of an offer to purchase any such Shares in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction, and is not a prospectus. This document may not be relied upon and should not be used for the purpose of making any investment decision.

 

The Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, and investors will not be entitled to the benefits of such Act.

 

Past performance is not a reliable indicator of current of future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

 

No recipient may forward, reproduce, distribute, or make available in whole or in part, this document (directly or indirectly) to any other person. The distribution of this document in certain jurisdictions may be restricted by law and recipients of this document should inform themselves about and observe any such restrictions and other applicable legal requirements in their jurisdictions. This document, and the information contained therein, is not for viewing, release, distribution or publication in or into the United States, Australia, Canada, the Republic of South Africa or Japan or any other jurisdiction where applicable laws prohibit its release, distribution or publication, and will not be made available to any national, resident or citizen of the United States, Australia, Canada, the Republic of South Africa or Japan. The distribution of this document in other jurisdictions may be restricted by law and persons into whose possession this document comes must inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the federal securities law of the United States or the laws of other jurisdictions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTUPGUWPUPUPWR
Date   Source Headline
21st Jul 20236:00 pmRNSDividend Declaration
20th Jul 20237:00 amRNSNet Asset Value & Publication of Monthly Report
29th Jun 20237:00 amRNSDividend Declaration
26th Jun 20236:02 pmRNS1st Quarter Results
23rd Jun 20235:30 pmRNSAnnouncement of Corporate Actions
23rd Jun 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th May 20231:36 pmRNSRevolving Credit Facility Extension
19th May 20237:00 amRNSNet Asset Value & Publication of Monthly Report
15th May 20234:31 pmRNSDistribution Announcement
24th Apr 20235:30 pmRNSSterling Dividend Amount
21st Apr 20235:00 pmRNSNet Asset Value & Publication of Monthly Report
12th Apr 20236:00 pmRNSAnnual Financial Report
11th Apr 20234:10 pmRNSHolding(s) in Company
30th Mar 20234:10 pmRNSDividend Declaration
23rd Mar 20237:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSLiquidating Share Class Distribution Announcement
22nd Feb 20237:00 amRNSNet Asset Value & Publication of Monthly Report
30th Jan 20237:00 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th Jan 20236:00 pmRNSDividend Declaration
12th Jan 20236:17 pmRNSMPLF Director / PDMR Shareholding
12th Jan 20236:00 pmRNSCompany Investment Manager Acquired by Investcorp
10th Jan 20236:00 pmRNSHolding(s) in Company
28th Dec 20226:00 pmRNSDividend Declaration
22nd Dec 20226:30 pmRNSNotice of Ordinary Share Re-designation
22nd Dec 20226:30 pmRNSChanges to the Board of Directors
21st Dec 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
2nd Dec 20227:30 amRNSCompany Investment Manager Agrees to Combination
22nd Nov 20226:00 pmRNS3rd Quarter Results
22nd Nov 20227:00 amRNSNet Asset Value & Publication of Monthly Report
17th Nov 20227:00 amRNSResults of General Meeting
17th Nov 20227:00 amRNSResults of Annual General Meeting
26th Oct 20227:00 amRNSNotice of Annual General Meeting
25th Oct 20227:00 amRNSNet Asset Value & Publication of Monthly Report
21st Oct 20226:00 pmRNSSterling Dividend Amount
29th Sep 20227:00 amRNSDividend Declaration
21st Sep 20227:00 amRNSNet Asset Value & Publication of Monthly Report
13th Sep 20226:00 pmRNSHalf-Year Report
19th Aug 20227:00 amRNSNet Asset Value & Publication of Monthly Report
26th Jul 20227:00 amRNSIssue of Equity
22nd Jul 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
21st Jul 20226:00 pmRNSDividend Declaration
15th Jul 20227:00 amRNSPublication of Key Investor Document
30th Jun 20227:00 amRNSDividend Declaration
23rd Jun 20227:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Jun 20227:00 amRNSTotal Voting Rights
20th Jun 20227:00 amRNSDirector/PDMR Shareholding
16th Jun 20225:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.